English Deutch Francais Espagnol
Catheter Lock Solution presentation

Citra-Lock™

Citra-Lock™ The safe, easy and effective way to lock every catheter

Citra-Lock™ The safe, easy and effective way to lock every catheter

Citra-Lock™ - catheter lock solution, anti-clotting and antimicrobial is one of the innovations from Dirinco.

The Citrate lock is based on tri-sodium citrate and can be safely used in all catheters!
The Dirinco Group is a Dutch and Swiss based company, with innovations mainly in the field of vascular access, hemotology, oncology and nephrology.

  • Citra-Lock™ 4% 5ml vial
  • Citra-Lock™ 30% 5ml vial
  • Citra-Lock™ 46,7% 5ml vial
  • CitraFlow™ 4% prefilled syringe 2,5ml

Citra-Lock™ and Citra-Flow™ are registered as a medical device (Class IIb)

NEW: Citra-Lock™ in a needle-free vial

Increase safety & Simplify handling

The new Citra-Lock™ vial features a drip free Luer-slip/Luer-lock connector:

  • Preventing microbial contamination
  • Protecting against needle stick injuries
  • Reducing handling steps
  • Promoting intuitive handling 
afbeelding
afbeelding

New European Guidelines Catheter Lock Solution

In the June 2010 edition of NDTplus the new European recommendation of preventing heamodialysis catheters by ERBP is published.
ERBP ( European Renal Best Practice) is the new guidance body of the European Renal Association–European Dialysis and Transplantation Association (ERA–EDTA).

The ERBP recommends to use Citrate lock of minimal 4% as the catheter lock solution instead of heparin.

'The clinical advantages offered by citrate have been confirmed in at least two meta-analyses Over time, progressively lower concentrations of citrate have been applied (from 46.7% to 4%) with still significantly better results, even in the latter case, than those obtained with heparin locks1' .

1. Vanholder et al, Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI), a position statement of European Renal Best Practice (ERBP). NDTplus June 2010

New scientific evidence Citra-Lock 46,7%

The European Neprhrology published an artcile of R. Lagaac ( Cambridge University Hospitals) with the following conclusion:
The incidence of the dialyse line related infection has fallen 75% in the six months, since Trisodium citaret 46,7%  was introduced compared with 6 months period prior to its introduction. Download article and advertisment of Citra-Lock.

Download artcile of R. Lagaac here > 

go to page 138!



Newsletter

Subscribe to our newsletter!

Please fill out the form below so we can inform when there are:
  • New scientific articles with Citra-Lock™
  • Exhibition & Congress dates
  • New product release information
  • Latest updates about Citra-lock™ guidelines






 *

* Required Fields




Signout from our newsletter